Biodesix, Inc. — Balance Sheet Charts
8 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Debt Structure
Working Capital Components
Total Assets↓-10.0% -$10M
$87M
Current Assets↓-17.6% -$7M
$33M
Cash & Equivalents↓-27.7% -$7M
$19M
Receivables↑+5.0% +$433K
$9M
Net PPE↓-10.8% -$3M
$25M
Goodwill↑+0.0% +$0
$15M
Intangibles↓-33.9% -$2M
$4M
Total Liabilities↑+17.8% +$14M
$90M
Current Liabilities↑+21.8% +$3M
$17M
Account Payables↑+40.4% +$886K
$3M
Long-Term Debt↑+24.9% +$10M
$50M
Stockholders Equity↓-111.8% -$23M
$-2M
Retained Earnings↓-7.6% -$35M
$-498M
Operating Lease ROU Asset↑+69.6% +$1M
$3M
Operating Lease Liability↑+2.3% +$575K
$25M
Gross PP&E↑+1.0% +$371K
$37M
Accumulated Depreciation↑+37.0% +$3M
$13M
Debt Due Y1↓-71.4% -$15K
$6K
Debt Due Y2↑+999900.0% +$50M
$50M
Debt Due Y3
—
Debt Due Y4
—
Debt Due Y5
—
Total Debt Carrying Amount↑+24.9% +$10M
$50M
Contract Liability↑+41.7% +$283K
$961K
Contract Liability (Current)↑+41.7% +$283K
$961K
Contract Liability (Noncurrent)
—